Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388737 | PMC |
http://dx.doi.org/10.1038/s41385-020-0329-z | DOI Listing |
Biomolecules
October 2023
Instituto de Investigaciones Biomédicas, Departamento de Inmunología, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
The β2 integrin CD11b/CD18, also known as complement receptor 3 (CR3), and the moonlighting protein aminopeptidase N (CD13), are two myeloid immune receptors with overlapping activities: adhesion, migration, phagocytosis of opsonized particles, and respiratory burst induction. Given their common functions, shared physical location, and the fact that some receptors can activate a selection of integrins, we hypothesized that CD13 could induce CR3 activation through an inside-out signaling mechanism and possibly have an influence on its membrane expression. We revealed that crosslinking CD13 on the surface of human macrophages not only activates CR3 but also influences its membrane expression.
View Article and Find Full Text PDFMucosal Immunol
November 2020
Centre for Molecular Therapeutics, The Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!